Ajay Kumar Meena

Dr. Ajay Kumar Meena


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2009 in Environmental Monitoring and Assessment
Verified
Journal Article
Closed access
PDF file
AMAjay Kumar Meena
Ajay Kumar Meena
PBParveen Bansal
Parveen Bansal
SKSanjiv Kumar
Sanjiv Kumar
MRM. M. Rao
M. M. Rao
VGV. K. Garg
V. K. Garg

4 February 2024 in Virulence
Verified
Journal Article
Open access
MKMeenakshi Kandpal
Meenakshi Kandpal
BBBudhadev Baral
Budhadev Baral
NVNidhi Varshney
Nidhi Varshney
AJAjay Kumar Jain
Ajay Kumar Jain
DCDebi Chatterji
Debi Chatterji
HJHem Chandra Jha
Hem Chandra Jha
Helicobacter pylori is a pathogenic bacterium that causes gastritis and gastric carcinoma. Besides gastric complications its potential link with gut-brain axis disruption and neurological disorders has also been reported. The current study investigated the plausible role and its associated molecular mechanism underlying H. pylori mediated gut-brain axis disruption and neuroinflammation leading to neurological modalities like Alzheimer's disease (AD). We have chosen the antimicrobial resistant and susceptible H. pylori strains on the basis of broth dilution method. We have observed the increased inflammatory response exerted by H. pylori strains in the gastric as well as in the neuronal compartment after treatment with Helicobacter pylori derived condition media (HPCM). Further, elevated expression of STAT1, STAT3, and AD-associated proteins- APP and APOE4 was monitored in HPCM-treated neuronal and neuron-astrocyte co-cultured cells. Excessive ROS generation has been found in these cells. The HPCM treatment to LN229 causes astrogliosis, evidenced by increased glial fibrillary acidic protein. Our results indicate the association of STAT3 as an important regulator in the H. pylori-mediated pathogenesis in neuronal cells. Notably, the inhibition of STAT3 by its specific inhibitor, BP-1-102, reduced the expression of pSTAT3 and AD markers in neuronal compartment induced by HPCM. Thus, our study demonstrates that H. pylori infection exacerbates inflammation in AGS cells and modulates the activity of STAT3 regulatory molecules. H. pylori secretome could affect neurological compartments by promoting STAT3 activation and inducing the expression of AD-associated signature markers. Further, pSTAT-3 inhibition mitigates the H. pylori associated neuroinflammation and amyloid pathology.

1 February 2021 in Heliyon
Verified
Journal Article
Open access
AMAjay Kumar Meena
Ajay Kumar Meena
PRP. Rekha
P. Rekha
APAyyam Perumal
Ayyam Perumal
MGM. Gokul
M. Gokul
KSK.N. Swathi
K.N. Swathi
RIR. Ilavarasan
R. Ilavarasan
Standardization is an important measurement for ensuring the quality control of herbal drugs. It has become essential to develop reliable, specific and sensitive quality control methods. Ashwagandhadi lehyam is an important Ayurvedic formulation containing Withania somnifera L., as one of the prime ingredient of formulation. The present study was undertaken to develop standardization parameters for Ashwagandhadi lehyam. Evaluation of various standardization parameters like organoleptic characters, Physico-chemical evaluation, HPTLC finger print profiling along with dominant bioactive markers and estimation of bioactive markers Withaferin-A by HPLC. The Rf value of Withaferin-A 0.35 and Withanolide-A 0.45 is in formulation and reference standards were found comparable under UV light at 254 nm and 540 nm. The HPLC chromatogram of Ashwagandhadi lehyam and standard Withaferin-A showed at Rt of 5.015 and 5.050 min. The percentage of Withaferin-A was 0.092% present in Ashwagandhadi lehyam formulation. Bioactive markers are characteristic to the ingredients or botanicals to identify the presence of ingredients in formulation easily. The presence of bioactive markers is possible and its verification through the HPTLC fingerprint profile and quantification of biomarker by HPLC are the best ways to identify evaluate the quality of the finished formulation in the course of development of a standardization protocol for quality control of Ayurvedic formulation.

14 August 2022 in Heliyon
Verified
Journal Article
Open access
AMAjay Kumar Meena
Ajay Kumar Meena
RIR. Ilavarasan
R. Ilavarasan
APAyyam Perumal
Ayyam Perumal
RSRavindra Singh
Ravindra Singh
VOVikas Ojha
Vikas Ojha
KDK.S. Dhiman
K.S. Dhiman
The Aim of the present research article is to proposing a conservative approach for the Cassia fistula by using of small branches instead of stem bark because of plant has many important chemical constituents which show different medicinal activity so consumption of plant is high. We studied here Comparative preliminary phytochemical screening test of the ethanol extract and aqueous extract of the stem bark and small branches of Cassia fistula obtained by cold maceration process. Physicochemical analysis of Cassia fistula was done to ascertain the quality of the raw material used in the study. Successive soxhlet extraction method used for the successive extraction of stem bark and small branches with different solvents for comparative chemical profile study by HPLC, LCMS, and GCMS. Molecular Docking Interaction of Abundant Medicinal Phytochemicals in the Liquid Chromatography−Mass Spectrometry (LC−MS) Analysis Data of C. fistula with the L. donovani Drug Target Proteins and Pancreatic lipase colipase target protein. The pH of the small branches was found slightly higher as compared to stem bark and the percentage of other parameters like total ash content, acid insoluble ash, loss on drying at 105 °C, water soluble extractive and alcohol soluble extractive values were found fewer in the small branches as compare to stem bark of the plant. It was observed that the number of peaks in stem bark and small branches of the plant sample were almost similar and the retention time of each peak in stem bark was coincide with the retention of small branches of the sample. Therefore, similarity was observed in stem bark and small branches of the Cassia fistula plant in HPLC, LC-MS and GC-MS. The results obtained from HPLC analysis shows that stem bark contains 0.0084% and small branches having 0.0257% of rhein in Cassia fistula. Compounds 3, 9 and 12 are present in Stem bark as well as small branches of C. fistula and Compounds 22, 32 and 37 are present in small branches only. All the compounds have very good binding energy (Kcal/mol) with the respective target proteins. The small branches have more active chemical constituents than stem bark against particular target proteins.

26 August 2021 in Future Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
AMAjay Kumar Meena
Ajay Kumar Meena
PRP. Rekha
P. Rekha
APAyyam Perumal
Ayyam Perumal
RIR. Ilavarasan
R. Ilavarasan
RSRavindra Singh
Ravindra Singh
KDK. S. Dhiman
K. S. Dhiman
Background: Anu Taila is an ancient medicated oil Ayurvedic preparation that is commonly used for nasya karma. It contains more than 25 herbs and goat milk as per the Ayurvedic Formulary of India (AFI). It strengthens the neck, shoulder, and chest muscles and improves the capacity of sense organs. It delays the aging process and reduces hair fall. Recent studies showed that it is also useful in COVID-19. In the current study, an attempt to develop quality control protocols and evaluate the standardization parameters like refractive index, iodine value, saponification value, peroxide value, acid value, rancidity, HPTLC fingerprint profile along with major bioactive compound and quantification of Berberine chloride, Negundoside, and Marmelosin by HPLC. Establishing quality protocol and standard parameters like physicochemical parameters and estimation of bioactive compounds of this preparation is significant for quality control. Results: In this study, HPTLC identifies bioactive chemical compounds like Berberine chloride, Marmelosin, Negundoside, glycyrrhizin, and para hydroxybenzoic acid (PHBA), Lupeol, Embelin, and Solasodine, which were present in the Anu Taila formulation. HPLC was used to estimate the bioactive marker compounds Negundoside, Berberine chloride, and Marmelosin were present in the Anu Taila formulation. The quantitative evaluation of Berberine chloride (0.0013%), Marmelosin (0.0366%), Negundoside (0.0086%) is present in Anu Taila formulation. Conclusion: The study reveals that sufficient quality control parameters were followed during the preparation of the formulation. Physicochemical analysis was carried out as per the guidelines of Ayurvedic Pharmacopeia of India. HPTLC and HPLC profiles generated in this particular study can be considered as a preliminary tool ascertaining the authenticity of Anu Taila.

28 December 2021 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
AMAjay Kumar Meena
Ajay Kumar Meena
ASArjun Singh
Arjun Singh
IRIlavarasan R.
Ilavarasan R.
MMMohit Motiwale
Mohit Motiwale
RSRavindra Singh
Ravindra Singh
Narayanam SrikanthNarayanam Srikanth
Narayanam Srikanth
Ayurveda is an ancient science of India and helps the human body to keep fit while providing cures from indigenous plants, animal and mineral origin products for various ailments. In Ayurveda literature, Berberis aristata has been described as a major plant possess antidiarrheal, antimicrobial, antiprotozoal and antitrachoma activity and used in for several remedies including diarrhea, chronic rheumatism, jaundice, skin diseases, syphilis and urinary disorders. Berberis aristata contains photoactive constituents such as berberine, oxyberberine, berbamine, aromoline, a protoberberine alkaloid karachine, palmatine, oxycanthine and taxilamine and tannins, sugar, starch. The present study has been designed to develop a quality control protocol for the coded Ayurvedic drug by analyzing the reference standard of bioactive compound present in the formulation and respective ingredient. The Rf value of berberine chloride reference standard 0.05 was visible in test solution of Berberis aristata stem as well as in coded Ayurvedic drug extract and found comparable under UV 254 nm and 366 nm, respectively. The quantitative evaluation revealed the presence of berberine chloride in the coded Ayurvedic drug and Berberis aristata DC stem extract was 0.1261% and 5.3936%, respectively.